The global intravenous solutions market size was US$ 11,857.7 million in 2021. The global intravenous solutions market size is estimated to reach US$ 24,302.8 million by 2030, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period from 2022 to 2030.
Intravenous fluid restriction is the control of the quantity of fluid obtained intravenously that is via the bloodstream. The fluid is given from a bag attached to an intravenous line. This is a narrow tube, usually known as IV, that is inserted into one of the veins. Fluids are administered this way for different causes that may contain adequate command of the quantity provided. Without authority, the rate of fluid management depends on gravity independently. This can result in acquiring either too much or too little fluid.

Factors Influencing Market Growth

? The rise in the majority of malnutrition, the rapid response time and higher efficacy related to intravenous resolution treatment, and the increase in the geriatric population drive the expansion of the overall market.
? The rise in the majority of cancer and an increase in the natality rate is expected to drive the overall market expansion.
? Lack of skilled healthcare specialists and difficulties of intravenous administration treatment is anticipated to restrict the expansion of the overall market.

Effect of the COVID-19 Pandemic

The COVID-19 pandemic affected the intravenous solutions industry in a fairly positive way. According to the guidelines by the American Society for Parenteral and Enteral Nutrition (ASPEN), in 2020, early parenteral nutrition should be initiated as soon as possible in high-risk patients for whom early gastric enteral nutrition is not feasible. It will bring down the concerns for ischemic bowel and also reduce droplet aerosol transmission to healthcare providers by avoiding procedures involved in the initial placement and maintenance of an enteral access device.

Regional Analysis

Europe accounted for the largest intravenous solutions market share in 2021 and is expected to hold its dominance during the analysis period, Due to the existence of an extensive patient population, the strong existence of fundamental players, the comfort of drug availability, well-developed healthcare infrastructure, favorable refund guidelines in the healthcare system, large number of research, development and invention activities and higher use of developed therapeutics.

Leading Competitors
The prominent players in the global intravenous solutions market are:
? Vifor Pharma Management Ltd.
? Sichuan Kelun Pharmaceutical
? Salius Pharma Private Limited
? Otsuka Pharmaceutical
? JW Life Science
? Soxa Formulations & Research
? Baxter International
? Amanta Healthcare
? Grifols S.A
? Fresenius Kabi AG
? Others
Segmentation Analysis
The global intravenous solutions market segmentation focuses on Type, Composition, End User, and Region.
Segmentation on the basis of Type
? Partial Parenteral Nutrition
o Age Group
? Pediatric
? Adult
? Total Parenteral Nutrition
o Age Group
? Pediatric
? Adult

Segmentation on the basis of Composition
? Carbohydrates
? Vitamins and Minerals
? Single Dose Amino Acids
? Parenteral Lipid Emulsion
? Others

Segmentation on the basis of End-User
? Hospitals and Clinics
? Ambulatory Surgery Centers
? Home care set

Segmentation on the basis of Region

? North America
? The U.S.
? Canada
? Mexico
? Europe
? Western Europe
? The UK
? Germany
? France
? Italy
? Spain
? Rest of Western Europe
? Eastern Europe
? Poland
? Russia
? Rest of Eastern Europe
? Asia Pacific
? China
? India
? Japan
? Australia & New Zealand
? ASEAN
? Rest of Asia Pacific
? Middle East & Africa (MEA)
? UAE
? Saudi Arabia
? South Africa
? Rest of MEA
? South America
? Brazil
? Argentina
? Rest of South America